We are live on ! Find out more
DMAQR

Deep Medicine Acquisition Corp. Rights
DMAQR

Delisted

DMAQR was delisted on the 31st of January, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in Deep Medicine Acquisition Corp. Rights in 2024 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 24 → 0 (-24)

100% less capital invested

Capital invested by funds: $1.85M → $0 (-$1.85M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 24

Holders
–
Holders Change
-24
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
24
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
HCM
Highbridge Capital Management
New York
-$229K
2
OCAM
Owl Creek Asset Management
New York
-$217K
3
CAC
Cowen and Company
New York
-$166K
4
YCM
Yakira Capital Management
Connecticut
-$147K
5
AA
AQR Arbitrage
Connecticut
-$111K
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
1
Highbridge Capital Management
New York
– -$229K -762,301 Closed
OCAM
2
Owl Creek Asset Management
New York
– -$217K -722,439 Closed
CAC
3
Cowen and Company
New York
– -$166K -553,167 Closed
YCM
4
Yakira Capital Management
Connecticut
– -$147K -489,668 Closed
AA
5
AQR Arbitrage
Connecticut
– -$111K -369,302 Closed
SOA
6
Sea Otter Advisors
Florida
– -$90K -300,000 Closed
SCM
7
Shaolin Capital Management
Florida
– -$90K -300,000 Closed
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
– -$89K -296,800 Closed
Walleye Capital
9
Walleye Capital
New York
– -$80.9K -269,792 Closed
WA
10
Whitebox Advisors
Minnesota
– -$75K -250,000 Closed
PC
11
Periscope Capital
Ontario, Canada
– -$72.6K -241,900 Closed
CH
12
CVI Holdings
Delaware
– -$69.2K -230,731 Closed
SCM
13
Saba Capital Management
New York
– -$50.7K -210,576 Closed
MTCM
14
Mint Tower Capital Management
Netherlands
– -$58K -194,190 Closed
PL
15
Parkwood LLC
Ohio
– -$47K -157,100 Closed
Walleye Trading
16
Walleye Trading
New York
– -$45.5K -151,758 Closed
RCM
17
Rivernorth Capital Management
Florida
– -$45K -150,000 Closed
KPF
18
K2 Principal Fund
Ontario, Canada
– -$40.4K -134,514 Closed
CS
19
Clear Street
New York
– -$31.3K -104,246 Closed
FLC
20
Fifth Lane Capital
Texas
– -$30K -100,000 Closed
MC
21
Meteora Capital
Florida
– -$24.2K -80,646 Closed
TCM
22
Tuttle Capital Management
Connecticut
– -$20.7K -69,024 Closed
HF
23
HRT Financial
New York
– -$14K -48,400 Closed
Millennium Management
24
Millennium Management
New York
– -$9.9K -33,000 Closed

DMAQR Hedge Fund Activity: Q1 2024 in Review

0 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Deep Medicine Acquisition Corp. Rights (DMAQR) for Q1 2024, worth a combined $0 — down 100% from $1.85M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of DMAQR and 0 opened new positions — a net loss of 24 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Highbridge Capital Management, exiting entirely with an estimated $229K sold.

  • 0 institutional investors held Deep Medicine Acquisition Corp. Rights (DMAQR) as of Q1 2024, down from 24 in Q4 2023.
  • Funds reported $0 of Deep Medicine Acquisition Corp. Rights stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Deep Medicine Acquisition Corp. Rights positions in Q1 2024 and 24 closed out, a net change of -24 holders.
  • The largest Deep Medicine Acquisition Corp. Rights seller in Q1 2024 was Highbridge Capital Management, an estimated $229K sold.

Based on aggregated 13F filings for Q1 2024.